Erratum to: The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia (J Neurol, (2013), 260, 906-909, 10.1007/s00415-012-6780-3);The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia

Journal of Neurology

Volumn 260, Issue 3, 2013, Pages 906-909

  Guthrie, Grant ^a   Pfeffer, Gerald ^a,b   Bailie, Maura ^a   Bradshaw, Karen ^a   Browning, Andrew C ^a   Horvath, Rita ^a,b   Chinnery, Patrick F ^a,b   Yu Wai Man, Patrick ^a,b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALERTNESS; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LETTER; MALE; MICROTUBULE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PYRAMIDAL TRACT; SPASTIC PARAPLEGIA; SPASTICITY; SPG4 GENE; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 84876473576     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-8008-9     Document Type: Erratum

References (15)

1. Salinas S, Proukakis C, Crosby A, Warner TT (2008) Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 7:1127-1138
2. Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151-1155
3. McDermott CJ, Grierson AJ, Wood JD et al (2003) Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann Neurol 54:748-759
4. Lumb JH, Connell JW, Allison R, Reid E (2012) The AAA ATPase spastin links microtubule severing to membrane modelling. Biochim Biophys Acta 1823:192-197
5. Schon EA, Przedborski S (2011) Mitochondria: the next (Neurode) generation. Neuron 70:1033-1053
6. Yu-Wai-Man P, Griffiths PG, Gorman GS et al (2010) Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133:771-786
7. Baker MR, Fisher KM, Whittaker RG, Griffiths PG, Yu-Wai-Man P, Chinnery PF (2011) Subclinical multisystem neurologic disease in "pure" Opa1 autosomal dominant optic atrophy. Neurology 77:1309-1312
8. Casari G, De Fusco M, Ciarmatori S et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973-983
9. Wilkinson PA, Crosby AH, Turner C et al (2004) A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain 127:973-980
10. van Gassen KL, van der Heijden CD, de Bot ST et al (2012) Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. Brain 135:2994-3004
11. Tallaksen CME, Guichart-Gomez E, Verpillat P et al (2003) Subtle cognitive impairment but no dementia in patients with spastin mutations. Arch Neurol 60:1113-1118
12. McMonagle P, Byrne P, Hutchinson M (2004) Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia. Neurology 62:407-410
13. Murphy S, Gorman G, Beetz C et al (2009) Dementia in SPG4 hereditary spastic paraplegia Clinical, genetic, and neuropathologic evidence. Neurology 73:378-384
14. Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695-699
15. Watson M (2002) Refining the ten-metre walking test for use with neurologically impaired people. Physiotherapy 88:386-397